Kilic A, Sultan I, Gleason TG, et al. - Among patients with chronic kidney disease, researchers compared contemporary results after surgical vs percutaneous coronary revascularization for multivessel coronary artery disease (MVCAD). Participants were recruited from a single institution and included patients suffering from MVCAD and having a decreased glomerular filtration rate (< 60 ml/min) who underwent coronary bypass surgery (CABG) or percutaneous coronary intervention (PCI) between 2010 and 2017. A composite outcome of mortality, stroke, myocardial infarction or repeat revascularization defined major adverse cardiac and cerebrovascular events (MACCE), which were assessed as the primary outcome. Findings revealed a lower MACCE rate in relation to CABG, vs PCI, among patients with MVCAD and chronic kidney disease. In MVCAD, multidisciplinary discussions concerning the optimal revascularization strategy are suggested to be crucial, especially in more complex scenarios such as chronic kidney disease.